The Primary Percutaneous Coronary Intervention Program in the Balearic Islands;Modelo de intervención coronaria percutánea primaria en las Islas Baleares

Revista Espanola de Cardiologia Suplementos

Volumn 11, Issue 3, 2011, Pages 35-43

  Peral, Vicente ^a   Carrillo, Andrés ^a   Bethencourt, Armando ^a   Fiol, Miguel ^a   Gómez Jaume, Alfredo ^a   Alameda, Mar ^a   Pascual, Marcos ^a   Fernández Palomeque, Carlos ^a   Rubert, Catalina ^b   Socías, Lorenzo ^b  

^a HOSPITAL UNIVERSITARIO SON ESPASES   (Spain)

^b HOSPITAL SON LLÀTZER   (Spain)

Author keywords

Fibrinolysis; Primary percutaneous coronary intervention; Reperfusion; ST elevation acute myocardial infarction; Trial

Indexed keywords

ARTICLE; CARDIOVASCULAR MORTALITY; CLINICAL TRIAL (TOPIC); HEALTH CARE SYSTEM; HEALTH PROGRAM; HOSPITAL DISCHARGE; HUMAN; MORBIDITY; PERCUTANEOUS CORONARY INTERVENTION; SPAIN; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION;

EID: 84867092534     PISSN: 11313587     EISSN: 15792250     Source Type: Journal    
DOI: 10.1016/S1131-3587(11)13008-3     Document Type: Article

References (35)

1. Plan Integral de Cardiopatía Isquémica 2004-2007 2003, Ministerio de Sanidad y Consumo, Madrid.
2. Estrategia en Cardiopatía Isquémica del Sistema Nacional de Salud 2006, Ministerio de Sanidad y Consumo, Madrid.
3. Estadística de defunciones según la causa de muerte, 1951-2007. Madrid: Instituto Nacional de Estadística. Disponible en: http://www.ine.es/inebase/.
4. Marrugat J., Elosúa R., Martí H. Epidemiología de la cardiopatía isquémica en España: estimación del número de casos y de las tendencias entre 1997 y 2005. Rev Esp Cardiol. 2002, 55:337-346.
5. Antman E.M., Morrow D.A., McCabe C.H., Murphy S.A., Ruda M., Sadowski Z., et al. Enoxaparin versus unfractionated hepatin with fibrinolysis for ST-elevation myocardial infarction. N Engl J Med. 2006, 354:1477-1488.
6. Ferreira-González I, Permanyer-Miralda C, Marrugat J, Heras M, Cuñat J, Civeira E, et al. Estudio MASCARA (Manejo del Síndrome Coronario Agudo. Registro Actualizado). Resultados globales. Rev Esp Cardiol. 2008, 61:803-816.
7. Ahmed S., Antman E.M., Murphy S.A., Giugliano R.P., Cañón C.P., Blanco H., et al. Poor outcomes after fibrinolytic therapy for ST-segment elevation myocardial infarction: impact of age (a meta-analysis of a decade of trials). J Thromb Thrombolysis. 2006, 21:119-129.
8. Guías de Práctica Clínica de la Sociedad Europea de Cardiología (ESC). Manejo del infarto agudo de miocardio en pacientes con elevación persistente del segmento ST [Versión corregida el 22/7/2009]. Rev Esp Cardiol. 2009, 62:e1-e47. Grupo de Trabajo de la Sociedad Europea de Cardiología (ESC) sobre el manejo del infarto agudo de miocardio con elevación del segmento ST (IAMCEST).
9. Antman E.M., Hand M., Armstrong P.W., Bates E.R., Green L.A., Hlasyamani L.K., et al. 2007 focused update of the ACC/AHA 2004 guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2008, 51:210-247.
10. Keeley E.C., Boura J.A., Grines C.L. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials. Lancet. 2003, 361:13-20.
11. Estadística de defunciones según la causa de muerte, 1951-2007. Madrid: Instituto Nacional de Estadística. Disponible en: http://www.ine.es/inebase/.
12. Antman EM, Anbe DT, Armastrong PW, Bates ER, Green LA, Mano H, et al. ACC/AHA guidelines for the managent of patients with ST-elevation myocardial infarction: A report of the American College of cardiology/American Heart Association Task Force on Practice Guidelines (commit-tee to Revise the 1999 Guidelines for the Management of Patients with Acute Myocardial Infarction). Disponible en: http://www.acc.org/clinical/guidelines/stemi/index.pdf.
13. The GUSTO Investigators An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. N Engl J Med. 1993, 329:673-682.
14. Fibrinolytic Therapy Trialists' (FTT) Collaborative Group Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomized trials of more than 1000 patients. Lancet 1994, 343:311-322.
15. Boersma E., Mass A.C., Deckers J.W., Simoons M.L. Early thrombolytic treatment in acute myocardial infarction: reappraisal of the golden hour. Lancet. 1996, 348:771-775.
16. Morrison L.J., Verbeek P.R., McDonald A.C., Sawadsky B.V., Cook D.J. Mortality and prehospital thrombolysis for acute myocardial infarction: A meta-analysis. JAMA. 2000, 283:2686-2692.
17. Bonnefoy E., Lapostolle F., Leizorovicz A., Steg G., McFadden E.P., Dubien P.Y., et al. Primary angioplasty versus prehospital fibrinolysis in acute myocardial infarction: a randomised study. Lancet. 2002, 360:825-829.
18. Danchin N., Blanchard D., Steg P.G., Sauval P., Hanania G., Goldstein P., et al. Impact of prehospital thrombolysis for acute myocardial infarction on 1 year. Circulation. 2004, 110:1909-1915.
19. Steg PG, Bonnefoy E, Chabaud S, Lapostolle M, Dubien PY, Cristofini P, et al. Comparison of Angioplasty and Prehospital Thrombolysis in Acute Myocardial Infarction (CAPTIM) Investigators. Impact of time to treatment on mortality after prehospital fibrinolysis or primary angioplasty. Circulation. 2003, 108:2851-2856.
20. Grines C.L., Serryus P., O'Neil W.W. Fibrinolitic therapy: is it a treatment of the past?. Circulaction. 2003, 107:2538-2542.
21. Dalby M., Bouzamondo A., Lechat P., Montalescot G., Bufalino V.J., Callaway C.W., et al. Transfer for primary angioplasty vesrsus inmediate trombolysis in acute myocardial infarction: a meta-analysis. Circulation. 2003, 108:1809-1814.
22. Boersma E. Does time matter? A pooled analysis of randomized clinical trials comparing primary percutaneous coronary intervention and in-hospital fibrinolysis in acute myocardial infarction patients. Eur Heart J. 2006, 27:779-788.
23. Gershlick A.H., Stephens-Lloyd A., Hughes S., Abrams K.R., Stevens S.E., Uren N.G., et al. Rescue angioplasty after failed thrombolytic therapy for acute myocardial infarction. N Engl J Med. 2005, 353:2758-2768.
24. Llevadot J, Giugliano RP, McCabe CH, Cannon CP, Antman EM, Murphy S, et al. Degree of residual stenosis in the culprit coronary artery after thrombolytic administration. Thrombolysis In Miocardial Infarction (TIMI) trials. Am J Cardiol. 2000, 85:1409-1413.
25. Dalby M., Bouzamondo A., Lechat P., Montalescot G. Transfer for primary angioplasty versus immediate thrombolysis in acute myocardial infarction: a meta-analysis. Circulation. 2003, 108:1809-1814.
26. Andersen HR, Nielsen TT, Rasmussen K, Thuesen L, Kelbaek H, Thayssen P, et al. A comparison of coronary angioplasty with fibrinolytic therapy in acute myocardial infarction. N Engl J Med. 2003, 349:733-742. for the DANAMI-2 Investigators.
27. Fernández-Aviles F., Alonso J.J., Castro-Beiras A., Vázquez N., Blanco J., Alonso-Briales J., et al. Routine invasive strategy within 24 hours of thrombolysis versus ischaemia- guided conservative approach for acute myocardial infarction with ST-segment elevation (GRACIA-1): a randomised controlled trial. Lancet. 2004, 364:1045-1053.
28. Fernández-Aviles F, Alonso JJ, Pena G, Blanco J, Alonso-Briales J, Lopez-Mesa J, et al. Primary angioplasty vs. early routine post-fibrinolysis angioplasty for acute myocardial infarction with ST-segment elevation: the GRACIA-2 non-inferiority, randomized, controlled trial. Eur Heart J. 2007, 28:949-960.
29. Armstrong PW. A comparison of pharmacologic therapy with/without timely coronary intervention vs. primary percutaneous intervention early after ST-elevation myocardial infarction: the WEST (Which Early ST-elevation myocardial infarction Therapy) study. Eur Heart J 2006, 27:1530-1538.
30. Cantor WJ, Fitchett D, Borgundvaag B, Ducas J, Heffernan M, Cohen EA, et al. TRANSFER-AMI Trial Investigators. Routine early angioplasty after fibrinolysis for acute myocardial infarction. N Engl J Med. 2009, 360:2705-2718.
31. Bohmer E., Hoffmann P., Abdelnoor M., Arnesen H., Halvorsen S. Efficacy and safety of immediate angioplasty versus ischemia-guidedmanagement after thrombolysis in acute myocardial infarction in areas with very long transfer distances: results of the NORDISTEMI (NORwegian study on DIstrict treatment of ST-Elevation Myocardial Infarction). J Am Coll Cardiol. 2010, 55:102-110.
32. Di Mario C., Dudek D., Piscione F., Mielecki W., Savonitto S., Murena E., et al. Immediate angioplasty versus standard therapy with rescue angioplasty after thrombolysis in the Combined Abciximab REteplase Stent Study in Acute Myocardial Infarction (CARESS-in-AMI): an open, prospective, randomised, multicentre trial. Lancet. 2008, 371:559-568.
33. Álvarez-León E., Elosua R., Zamora A., Aldasoro E., Galcera J., Vanaclocha H., et al. Recursos hospitalarios y letalidad por infarto de miocardio. Estudio IBERICA. Rev Esp Cardiol. 2004, 57:514-523.
34. Rubert C. El infarto agudo de miocardio en Mallorca. Un estudio poblacional [tesis doctoral] 1996, Universitat de les Illes Balears, Palma de Mallorca.
35. Van de Werf F., Ardissino D., Betriu A. Cokkinos DV, Falk E, Fox KAA, et al. Management of acute myocardial infarction in patients presenting with ST-segment elevation. The Task Force on the management of acute myocardial infarction of the European Society of Cardiology. Eur Heart J. 2003, 24:28-66.